NASDAQ:FUND - Sprott Focus Trust Stock Price, News, & Analysis

Sprott Focus Trust trades on the NASDAQ under the ticker symbol "FUND."

Sprott Focus Trust declared a quarterly dividend on Wednesday, March 6th. Investors of record on Friday, March 15th will be paid a dividend of $0.1196 per share on Friday, March 29th. This represents a $0.48 annualized dividend and a dividend yield of 7.17%. The ex-dividend date is Thursday, March 14th. View Sprott Focus Trust's Dividend History.

News stories about FUND stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sprott Focus Trust earned a news sentiment score of 1.9 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Some companies that are related to Sprott Focus Trust include Blackrock Muniyield Fund (MYD), Invesco Municipal Trust (VKQ), Invesco Trust for Investment GradeMncpls (VGM), Templeton Dragon Fund (TDF), John Hancock Financial Opprts Fund (BTO), Invesco California Value Mncpl Incm Trst (VCV), Western Asset Managed Municipals Fnd (MMU), The India Fund (IFN), Blackrock Muniassets Fund (MUA), BlackRock Debt Strategies Fund (DSU), Putnam Premier Income Trust (PPT), Nuveen Pennsylvania Invsmt Qlty Mncpl Fd (NQP), BlackRock MuniYield New York Insured Fnd (MYN), Dreyfus Strategic Muni. (LEO) and BlackRock MuniHolding Insured Investm (MFL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sprott Focus Trust investors own include Allena Pharmaceuticals (ALNA), Rigel Pharmaceuticals (RIGL), Ritter Pharmaceuticals (RTTR), Revolution Lighting Technologies (RVLT), Veru (VERU), Spark Networks (LOV), Protalix Biotherapeutics (PLX), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX) and ArQule (ARQL).

Sprott Focus Trust's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Rivernorth Capital Management LLC (4.29%), Wells Fargo & Company MN (2.47%), Northwestern Mutual Wealth Management Co. (1.34%), First Allied Advisory Services Inc. (0.93%), Morgan Stanley (0.49%) and Shaker Financial Services LLC (0.42%). Company insiders that own Sprott Focus Trust stock include Barbara Connolly Keady, James R Jr Pierce, Thomas W Ulrich and W Whitney George. View Institutional Ownership Trends for Sprott Focus Trust.

FUND stock was sold by a variety of institutional investors in the last quarter, including Shaker Financial Services LLC, Rivernorth Capital Management LLC and First Allied Advisory Services Inc.. View Insider Buying and Selling for Sprott Focus Trust.

FUND stock was purchased by a variety of institutional investors in the last quarter, including Northwestern Mutual Wealth Management Co., Wells Fargo & Company MN, Morgan Stanley, Sprott Inc. and HighTower Advisors LLC. Company insiders that have bought Sprott Focus Trust stock in the last two years include James R Jr Pierce, Thomas W Ulrich and W Whitney George. View Insider Buying and Selling for Sprott Focus Trust.

Shares of FUND can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of FUND stock can currently be purchased for approximately $6.67.

Sprott Focus Trust has a market capitalization of $173.55 million.